nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—ALB—stomach cancer	0.266	1	CbGaD
Mirabegron—BCHE—Irinotecan—stomach cancer	0.104	0.205	CbGbCtD
Mirabegron—ABCB1—Mitomycin—stomach cancer	0.103	0.203	CbGbCtD
Mirabegron—SLCO1A2—Methotrexate—stomach cancer	0.0516	0.102	CbGbCtD
Mirabegron—ALB—Irinotecan—stomach cancer	0.0504	0.0993	CbGbCtD
Mirabegron—ALB—Fluorouracil—stomach cancer	0.0484	0.0953	CbGbCtD
Mirabegron—ALB—Methotrexate—stomach cancer	0.0267	0.0526	CbGbCtD
Mirabegron—ABCB1—Irinotecan—stomach cancer	0.0264	0.052	CbGbCtD
Mirabegron—ABCB1—Docetaxel—stomach cancer	0.0193	0.0381	CbGbCtD
Mirabegron—CYP3A4—Irinotecan—stomach cancer	0.0158	0.0311	CbGbCtD
Mirabegron—ABCB1—Doxorubicin—stomach cancer	0.0144	0.0284	CbGbCtD
Mirabegron—ABCB1—Methotrexate—stomach cancer	0.014	0.0275	CbGbCtD
Mirabegron—CYP2D6—Doxorubicin—stomach cancer	0.0136	0.0268	CbGbCtD
Mirabegron—ORM1—bile—stomach cancer	0.0122	0.215	CbGeAlD
Mirabegron—CYP3A4—Docetaxel—stomach cancer	0.0116	0.0228	CbGbCtD
Mirabegron—BCHE—diaphragm—stomach cancer	0.0114	0.2	CbGeAlD
Mirabegron—CYP3A4—Doxorubicin—stomach cancer	0.00863	0.017	CbGbCtD
Mirabegron—ORM1—gall bladder—stomach cancer	0.00338	0.0596	CbGeAlD
Mirabegron—ALB—gall bladder—stomach cancer	0.00296	0.0523	CbGeAlD
Mirabegron—ORM1—hematopoietic system—stomach cancer	0.00191	0.0337	CbGeAlD
Mirabegron—SLCO1A2—hematopoietic system—stomach cancer	0.00169	0.0298	CbGeAlD
Mirabegron—Arbutamine—ADRB1—stomach cancer	0.00154	0.271	CrCbGaD
Mirabegron—Arbutamine—ADRB2—stomach cancer	0.0013	0.228	CrCbGaD
Mirabegron—ORM1—bone marrow—stomach cancer	0.00123	0.0216	CbGeAlD
Mirabegron—BCHE—hematopoietic system—stomach cancer	0.00119	0.0209	CbGeAlD
Mirabegron—SLCO1A2—digestive system—stomach cancer	0.00117	0.0207	CbGeAlD
Mirabegron—ORM1—endocrine gland—stomach cancer	0.0011	0.0194	CbGeAlD
Mirabegron—Labetalol—ADRB1—stomach cancer	0.00109	0.192	CrCbGaD
Mirabegron—ABCB1—blood vessel—stomach cancer	0.00106	0.0187	CbGeAlD
Mirabegron—BCHE—smooth muscle tissue—stomach cancer	0.00104	0.0184	CbGeAlD
Mirabegron—ORM1—liver—stomach cancer	0.000991	0.0175	CbGeAlD
Mirabegron—SLCO1A2—endocrine gland—stomach cancer	0.00097	0.0171	CbGeAlD
Mirabegron—Labetalol—ADRB2—stomach cancer	0.00092	0.162	CrCbGaD
Mirabegron—SLCO1A2—liver—stomach cancer	0.000874	0.0154	CbGeAlD
Mirabegron—ALB—liver—stomach cancer	0.000869	0.0153	CbGeAlD
Mirabegron—Propafenone—ADRB1—stomach cancer	0.000836	0.147	CrCbGaD
Mirabegron—BCHE—digestive system—stomach cancer	0.000825	0.0145	CbGeAlD
Mirabegron—CYP3A4—hematopoietic system—stomach cancer	0.000799	0.0141	CbGeAlD
Mirabegron—CYP2D6—hematopoietic system—stomach cancer	0.000786	0.0139	CbGeAlD
Mirabegron—BCHE—bone marrow—stomach cancer	0.00076	0.0134	CbGeAlD
Mirabegron—ORM1—lymph node—stomach cancer	0.00076	0.0134	CbGeAlD
Mirabegron—BCHE—endocrine gland—stomach cancer	0.000682	0.012	CbGeAlD
Mirabegron—ALB—lymph node—stomach cancer	0.000666	0.0118	CbGeAlD
Mirabegron—BCHE—liver—stomach cancer	0.000615	0.0108	CbGeAlD
Mirabegron—ABCB1—hematopoietic system—stomach cancer	0.000565	0.00997	CbGeAlD
Mirabegron—CYP3A4—digestive system—stomach cancer	0.000555	0.00979	CbGeAlD
Mirabegron—CYP2D6—digestive system—stomach cancer	0.000547	0.00964	CbGeAlD
Mirabegron—ABCB1—epithelium—stomach cancer	0.000517	0.00911	CbGeAlD
Mirabegron—Aspartate aminotransferase increased—Capecitabine—stomach cancer	0.000475	0.0039	CcSEcCtD
Mirabegron—Nasopharyngitis—Capecitabine—stomach cancer	0.000472	0.00388	CcSEcCtD
Mirabegron—BCHE—lymph node—stomach cancer	0.000471	0.00831	CbGeAlD
Mirabegron—Dry eye—Epirubicin—stomach cancer	0.000468	0.00384	CcSEcCtD
Mirabegron—Gastritis—Capecitabine—stomach cancer	0.000467	0.00384	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Capecitabine—stomach cancer	0.000466	0.00382	CcSEcCtD
Mirabegron—ABCB1—pancreas—stomach cancer	0.00046	0.00812	CbGeAlD
Mirabegron—Back pain—Irinotecan—stomach cancer	0.000459	0.00377	CcSEcCtD
Mirabegron—Abdominal distension—Capecitabine—stomach cancer	0.000459	0.00377	CcSEcCtD
Mirabegron—CYP3A4—endocrine gland—stomach cancer	0.000459	0.00809	CbGeAlD
Mirabegron—Bladder pain—Epirubicin—stomach cancer	0.000458	0.00376	CcSEcCtD
Mirabegron—Neoplasm—Epirubicin—stomach cancer	0.000458	0.00376	CcSEcCtD
Mirabegron—Cystitis noninfective—Doxorubicin—stomach cancer	0.000458	0.00376	CcSEcCtD
Mirabegron—Influenza—Capecitabine—stomach cancer	0.000456	0.00375	CcSEcCtD
Mirabegron—Cystitis—Doxorubicin—stomach cancer	0.000453	0.00372	CcSEcCtD
Mirabegron—CYP2D6—endocrine gland—stomach cancer	0.000452	0.00796	CbGeAlD
Mirabegron—Vaginal infection—Doxorubicin—stomach cancer	0.000443	0.00363	CcSEcCtD
Mirabegron—Dry eye—Doxorubicin—stomach cancer	0.000433	0.00356	CcSEcCtD
Mirabegron—Vision blurred—Fluorouracil—stomach cancer	0.000429	0.00352	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Capecitabine—stomach cancer	0.000424	0.00348	CcSEcCtD
Mirabegron—Neoplasm—Doxorubicin—stomach cancer	0.000424	0.00348	CcSEcCtD
Mirabegron—Bladder pain—Doxorubicin—stomach cancer	0.000424	0.00348	CcSEcCtD
Mirabegron—Infestation—Docetaxel—stomach cancer	0.00042	0.00345	CcSEcCtD
Mirabegron—Infestation NOS—Docetaxel—stomach cancer	0.00042	0.00345	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Docetaxel—stomach cancer	0.000417	0.00342	CcSEcCtD
Mirabegron—CYP3A4—liver—stomach cancer	0.000414	0.0073	CbGeAlD
Mirabegron—Vascular purpura—Epirubicin—stomach cancer	0.000411	0.00338	CcSEcCtD
Mirabegron—Hypertension—Irinotecan—stomach cancer	0.00041	0.00337	CcSEcCtD
Mirabegron—CYP2D6—liver—stomach cancer	0.000407	0.00718	CbGeAlD
Mirabegron—Infestation NOS—Capecitabine—stomach cancer	0.000407	0.00334	CcSEcCtD
Mirabegron—Infestation—Capecitabine—stomach cancer	0.000407	0.00334	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.000403	0.00331	CcSEcCtD
Mirabegron—Cerebrovascular accident—Methotrexate—stomach cancer	0.000401	0.00329	CcSEcCtD
Mirabegron—ABCB1—lymphoid tissue—stomach cancer	0.000398	0.00702	CbGeAlD
Mirabegron—Urinary tract infection—Capecitabine—stomach cancer	0.000395	0.00325	CcSEcCtD
Mirabegron—ABCB1—digestive system—stomach cancer	0.000393	0.00693	CbGeAlD
Mirabegron—Osteoarthritis—Methotrexate—stomach cancer	0.000393	0.00323	CcSEcCtD
Mirabegron—Infection—Irinotecan—stomach cancer	0.000385	0.00316	CcSEcCtD
Mirabegron—Purpura—Epirubicin—stomach cancer	0.000382	0.00313	CcSEcCtD
Mirabegron—Vascular purpura—Doxorubicin—stomach cancer	0.00038	0.00312	CcSEcCtD
Mirabegron—Rhinitis—Docetaxel—stomach cancer	0.000378	0.00311	CcSEcCtD
Mirabegron—Cerebrovascular accident—Epirubicin—stomach cancer	0.000375	0.00308	CcSEcCtD
Mirabegron—Urinary tract disorder—Docetaxel—stomach cancer	0.000372	0.00306	CcSEcCtD
Mirabegron—Connective tissue disorder—Docetaxel—stomach cancer	0.000371	0.00304	CcSEcCtD
Mirabegron—Urethral disorder—Docetaxel—stomach cancer	0.00037	0.00304	CcSEcCtD
Mirabegron—Infection—Fluorouracil—stomach cancer	0.000369	0.00303	CcSEcCtD
Mirabegron—Osteoarthritis—Epirubicin—stomach cancer	0.000368	0.00302	CcSEcCtD
Mirabegron—Rhinitis—Capecitabine—stomach cancer	0.000366	0.00301	CcSEcCtD
Mirabegron—ABCB1—bone marrow—stomach cancer	0.000362	0.00639	CbGeAlD
Mirabegron—Tachycardia—Fluorouracil—stomach cancer	0.000362	0.00298	CcSEcCtD
Mirabegron—Urinary tract disorder—Capecitabine—stomach cancer	0.000361	0.00296	CcSEcCtD
Mirabegron—Connective tissue disorder—Capecitabine—stomach cancer	0.000359	0.00295	CcSEcCtD
Mirabegron—Urethral disorder—Capecitabine—stomach cancer	0.000358	0.00294	CcSEcCtD
Mirabegron—Erythema multiforme—Docetaxel—stomach cancer	0.000357	0.00293	CcSEcCtD
Mirabegron—Breast disorder—Methotrexate—stomach cancer	0.000355	0.00292	CcSEcCtD
Mirabegron—Purpura—Doxorubicin—stomach cancer	0.000353	0.0029	CcSEcCtD
Mirabegron—Eye disorder—Docetaxel—stomach cancer	0.000352	0.00289	CcSEcCtD
Mirabegron—Cardiac disorder—Docetaxel—stomach cancer	0.00035	0.00287	CcSEcCtD
Mirabegron—Cerebrovascular accident—Doxorubicin—stomach cancer	0.000347	0.00285	CcSEcCtD
Mirabegron—Erythema multiforme—Capecitabine—stomach cancer	0.000345	0.00284	CcSEcCtD
Mirabegron—Eye disorder—Capecitabine—stomach cancer	0.000341	0.0028	CcSEcCtD
Mirabegron—Dyspepsia—Irinotecan—stomach cancer	0.000341	0.0028	CcSEcCtD
Mirabegron—Osteoarthritis—Doxorubicin—stomach cancer	0.00034	0.00279	CcSEcCtD
Mirabegron—Cardiac disorder—Capecitabine—stomach cancer	0.000339	0.00278	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000338	0.00278	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000335	0.00275	CcSEcCtD
Mirabegron—Fatigue—Irinotecan—stomach cancer	0.000334	0.00274	CcSEcCtD
Mirabegron—Breast disorder—Epirubicin—stomach cancer	0.000332	0.00273	CcSEcCtD
Mirabegron—Constipation—Irinotecan—stomach cancer	0.000331	0.00272	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Epirubicin—stomach cancer	0.000331	0.00272	CcSEcCtD
Mirabegron—Nasopharyngitis—Epirubicin—stomach cancer	0.000329	0.0027	CcSEcCtD
Mirabegron—Dyspepsia—Fluorouracil—stomach cancer	0.000327	0.00268	CcSEcCtD
Mirabegron—Gastritis—Epirubicin—stomach cancer	0.000325	0.00267	CcSEcCtD
Mirabegron—ABCB1—endocrine gland—stomach cancer	0.000325	0.00573	CbGeAlD
Mirabegron—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.000324	0.00266	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000321	0.00263	CcSEcCtD
Mirabegron—Abdominal distension—Epirubicin—stomach cancer	0.00032	0.00263	CcSEcCtD
Mirabegron—Influenza—Epirubicin—stomach cancer	0.000318	0.00261	CcSEcCtD
Mirabegron—Back pain—Docetaxel—stomach cancer	0.000318	0.00261	CcSEcCtD
Mirabegron—Gastrointestinal pain—Irinotecan—stomach cancer	0.000317	0.0026	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000316	0.00259	CcSEcCtD
Mirabegron—Back pain—Capecitabine—stomach cancer	0.000308	0.00253	CcSEcCtD
Mirabegron—Breast disorder—Doxorubicin—stomach cancer	0.000307	0.00253	CcSEcCtD
Mirabegron—Abdominal pain—Irinotecan—stomach cancer	0.000306	0.00252	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.000306	0.00252	CcSEcCtD
Mirabegron—Nasopharyngitis—Doxorubicin—stomach cancer	0.000304	0.0025	CcSEcCtD
Mirabegron—Infestation NOS—Methotrexate—stomach cancer	0.000303	0.00249	CcSEcCtD
Mirabegron—Infestation—Methotrexate—stomach cancer	0.000303	0.00249	CcSEcCtD
Mirabegron—Gastritis—Doxorubicin—stomach cancer	0.000301	0.00247	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.0003	0.00247	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.0003	0.00246	CcSEcCtD
Mirabegron—Vision blurred—Capecitabine—stomach cancer	0.0003	0.00246	CcSEcCtD
Mirabegron—Abdominal distension—Doxorubicin—stomach cancer	0.000296	0.00243	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000295	0.00243	CcSEcCtD
Mirabegron—Urticaria—Fluorouracil—stomach cancer	0.000295	0.00242	CcSEcCtD
Mirabegron—Influenza—Doxorubicin—stomach cancer	0.000294	0.00242	CcSEcCtD
Mirabegron—ABCB1—liver—stomach cancer	0.000293	0.00516	CbGeAlD
Mirabegron—Palpitations—Docetaxel—stomach cancer	0.00029	0.00238	CcSEcCtD
Mirabegron—Hypertension—Docetaxel—stomach cancer	0.000283	0.00233	CcSEcCtD
Mirabegron—Infestation—Epirubicin—stomach cancer	0.000283	0.00233	CcSEcCtD
Mirabegron—Infestation NOS—Epirubicin—stomach cancer	0.000283	0.00233	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000281	0.00231	CcSEcCtD
Mirabegron—Palpitations—Capecitabine—stomach cancer	0.000281	0.00231	CcSEcCtD
Mirabegron—Arthralgia—Docetaxel—stomach cancer	0.00028	0.0023	CcSEcCtD
Mirabegron—Asthenia—Irinotecan—stomach cancer	0.000278	0.00228	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000278	0.00228	CcSEcCtD
Mirabegron—Urinary tract infection—Epirubicin—stomach cancer	0.000275	0.00226	CcSEcCtD
Mirabegron—Hypertension—Capecitabine—stomach cancer	0.000274	0.00225	CcSEcCtD
Mirabegron—Dry mouth—Docetaxel—stomach cancer	0.000273	0.00225	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000273	0.00224	CcSEcCtD
Mirabegron—Arthralgia—Capecitabine—stomach cancer	0.000271	0.00222	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000269	0.00221	CcSEcCtD
Mirabegron—Urinary tract disorder—Methotrexate—stomach cancer	0.000268	0.0022	CcSEcCtD
Mirabegron—Urethral disorder—Methotrexate—stomach cancer	0.000266	0.00219	CcSEcCtD
Mirabegron—Infection—Docetaxel—stomach cancer	0.000266	0.00219	CcSEcCtD
Mirabegron—Sinusitis—Epirubicin—stomach cancer	0.000266	0.00218	CcSEcCtD
Mirabegron—Diarrhoea—Irinotecan—stomach cancer	0.000265	0.00218	CcSEcCtD
Mirabegron—Dry mouth—Capecitabine—stomach cancer	0.000265	0.00217	CcSEcCtD
Mirabegron—Pruritus—Fluorouracil—stomach cancer	0.000263	0.00216	CcSEcCtD
Mirabegron—Infestation NOS—Doxorubicin—stomach cancer	0.000262	0.00215	CcSEcCtD
Mirabegron—Infestation—Doxorubicin—stomach cancer	0.000262	0.00215	CcSEcCtD
Mirabegron—Tachycardia—Docetaxel—stomach cancer	0.000262	0.00215	CcSEcCtD
Mirabegron—Skin disorder—Docetaxel—stomach cancer	0.00026	0.00214	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.00026	0.00213	CcSEcCtD
Mirabegron—Infection—Capecitabine—stomach cancer	0.000258	0.00212	CcSEcCtD
Mirabegron—Erythema multiforme—Methotrexate—stomach cancer	0.000257	0.00211	CcSEcCtD
Mirabegron—Dizziness—Irinotecan—stomach cancer	0.000256	0.00211	CcSEcCtD
Mirabegron—Rhinitis—Epirubicin—stomach cancer	0.000255	0.00209	CcSEcCtD
Mirabegron—Urinary tract infection—Doxorubicin—stomach cancer	0.000255	0.00209	CcSEcCtD
Mirabegron—Eye disorder—Methotrexate—stomach cancer	0.000254	0.00209	CcSEcCtD
Mirabegron—Diarrhoea—Fluorouracil—stomach cancer	0.000254	0.00209	CcSEcCtD
Mirabegron—Tachycardia—Capecitabine—stomach cancer	0.000253	0.00208	CcSEcCtD
Mirabegron—Cardiac disorder—Methotrexate—stomach cancer	0.000252	0.00207	CcSEcCtD
Mirabegron—Skin disorder—Capecitabine—stomach cancer	0.000252	0.00207	CcSEcCtD
Mirabegron—Urinary tract disorder—Epirubicin—stomach cancer	0.000251	0.00206	CcSEcCtD
Mirabegron—Connective tissue disorder—Epirubicin—stomach cancer	0.00025	0.00205	CcSEcCtD
Mirabegron—Urethral disorder—Epirubicin—stomach cancer	0.000249	0.00205	CcSEcCtD
Mirabegron—Sinusitis—Doxorubicin—stomach cancer	0.000246	0.00202	CcSEcCtD
Mirabegron—Dizziness—Fluorouracil—stomach cancer	0.000246	0.00202	CcSEcCtD
Mirabegron—Rash—Irinotecan—stomach cancer	0.000244	0.00201	CcSEcCtD
Mirabegron—Dermatitis—Irinotecan—stomach cancer	0.000244	0.00201	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000244	0.00201	CcSEcCtD
Mirabegron—Headache—Irinotecan—stomach cancer	0.000243	0.00199	CcSEcCtD
Mirabegron—Erythema multiforme—Epirubicin—stomach cancer	0.000241	0.00198	CcSEcCtD
Mirabegron—Eye disorder—Epirubicin—stomach cancer	0.000238	0.00195	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000236	0.00194	CcSEcCtD
Mirabegron—Cardiac disorder—Epirubicin—stomach cancer	0.000236	0.00194	CcSEcCtD
Mirabegron—Rhinitis—Doxorubicin—stomach cancer	0.000236	0.00194	CcSEcCtD
Mirabegron—Dyspepsia—Docetaxel—stomach cancer	0.000236	0.00194	CcSEcCtD
Mirabegron—Rash—Fluorouracil—stomach cancer	0.000234	0.00192	CcSEcCtD
Mirabegron—Dermatitis—Fluorouracil—stomach cancer	0.000234	0.00192	CcSEcCtD
Mirabegron—Headache—Fluorouracil—stomach cancer	0.000233	0.00191	CcSEcCtD
Mirabegron—Urinary tract disorder—Doxorubicin—stomach cancer	0.000232	0.00191	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000231	0.0019	CcSEcCtD
Mirabegron—Connective tissue disorder—Doxorubicin—stomach cancer	0.000231	0.0019	CcSEcCtD
Mirabegron—Fatigue—Docetaxel—stomach cancer	0.000231	0.0019	CcSEcCtD
Mirabegron—Urethral disorder—Doxorubicin—stomach cancer	0.000231	0.0019	CcSEcCtD
Mirabegron—Nausea—Irinotecan—stomach cancer	0.00023	0.00189	CcSEcCtD
Mirabegron—Constipation—Docetaxel—stomach cancer	0.000229	0.00188	CcSEcCtD
Mirabegron—Back pain—Methotrexate—stomach cancer	0.000229	0.00188	CcSEcCtD
Mirabegron—Dyspepsia—Capecitabine—stomach cancer	0.000228	0.00188	CcSEcCtD
Mirabegron—ABCB1—lymph node—stomach cancer	0.000225	0.00396	CbGeAlD
Mirabegron—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000224	0.00184	CcSEcCtD
Mirabegron—Fatigue—Capecitabine—stomach cancer	0.000224	0.00184	CcSEcCtD
Mirabegron—Vision blurred—Methotrexate—stomach cancer	0.000223	0.00183	CcSEcCtD
Mirabegron—Erythema multiforme—Doxorubicin—stomach cancer	0.000223	0.00183	CcSEcCtD
Mirabegron—Constipation—Capecitabine—stomach cancer	0.000222	0.00182	CcSEcCtD
Mirabegron—Nausea—Fluorouracil—stomach cancer	0.000221	0.00181	CcSEcCtD
Mirabegron—Eye disorder—Doxorubicin—stomach cancer	0.00022	0.00181	CcSEcCtD
Mirabegron—Gastrointestinal pain—Docetaxel—stomach cancer	0.000219	0.0018	CcSEcCtD
Mirabegron—Cardiac disorder—Doxorubicin—stomach cancer	0.000218	0.00179	CcSEcCtD
Mirabegron—Back pain—Epirubicin—stomach cancer	0.000214	0.00176	CcSEcCtD
Mirabegron—Gastrointestinal pain—Capecitabine—stomach cancer	0.000212	0.00174	CcSEcCtD
Mirabegron—Abdominal pain—Docetaxel—stomach cancer	0.000212	0.00174	CcSEcCtD
Mirabegron—Vision blurred—Epirubicin—stomach cancer	0.000209	0.00171	CcSEcCtD
Mirabegron—Urticaria—Capecitabine—stomach cancer	0.000206	0.00169	CcSEcCtD
Mirabegron—Abdominal pain—Capecitabine—stomach cancer	0.000205	0.00168	CcSEcCtD
Mirabegron—Arthralgia—Methotrexate—stomach cancer	0.000201	0.00165	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.0002	0.00164	CcSEcCtD
Mirabegron—Back pain—Doxorubicin—stomach cancer	0.000198	0.00163	CcSEcCtD
Mirabegron—Palpitations—Epirubicin—stomach cancer	0.000196	0.00161	CcSEcCtD
Mirabegron—Vision blurred—Doxorubicin—stomach cancer	0.000193	0.00159	CcSEcCtD
Mirabegron—Asthenia—Docetaxel—stomach cancer	0.000192	0.00158	CcSEcCtD
Mirabegron—Infection—Methotrexate—stomach cancer	0.000192	0.00158	CcSEcCtD
Mirabegron—Hypertension—Epirubicin—stomach cancer	0.000191	0.00157	CcSEcCtD
Mirabegron—Pruritus—Docetaxel—stomach cancer	0.00019	0.00156	CcSEcCtD
Mirabegron—Arthralgia—Epirubicin—stomach cancer	0.000189	0.00155	CcSEcCtD
Mirabegron—Skin disorder—Methotrexate—stomach cancer	0.000188	0.00154	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000187	0.00154	CcSEcCtD
Mirabegron—Asthenia—Capecitabine—stomach cancer	0.000186	0.00153	CcSEcCtD
Mirabegron—Dry mouth—Epirubicin—stomach cancer	0.000184	0.00151	CcSEcCtD
Mirabegron—Pruritus—Capecitabine—stomach cancer	0.000184	0.00151	CcSEcCtD
Mirabegron—Diarrhoea—Docetaxel—stomach cancer	0.000183	0.00151	CcSEcCtD
Mirabegron—Palpitations—Doxorubicin—stomach cancer	0.000181	0.00149	CcSEcCtD
Mirabegron—Infection—Epirubicin—stomach cancer	0.00018	0.00147	CcSEcCtD
Mirabegron—Diarrhoea—Capecitabine—stomach cancer	0.000178	0.00146	CcSEcCtD
Mirabegron—Dizziness—Docetaxel—stomach cancer	0.000177	0.00146	CcSEcCtD
Mirabegron—Hypertension—Doxorubicin—stomach cancer	0.000177	0.00145	CcSEcCtD
Mirabegron—Tachycardia—Epirubicin—stomach cancer	0.000176	0.00145	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000176	0.00145	CcSEcCtD
Mirabegron—Skin disorder—Epirubicin—stomach cancer	0.000176	0.00144	CcSEcCtD
Mirabegron—Arthralgia—Doxorubicin—stomach cancer	0.000174	0.00143	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000173	0.00142	CcSEcCtD
Mirabegron—Dizziness—Capecitabine—stomach cancer	0.000172	0.00141	CcSEcCtD
Mirabegron—Dry mouth—Doxorubicin—stomach cancer	0.000171	0.0014	CcSEcCtD
Mirabegron—Dyspepsia—Methotrexate—stomach cancer	0.00017	0.0014	CcSEcCtD
Mirabegron—Rash—Docetaxel—stomach cancer	0.000169	0.00139	CcSEcCtD
Mirabegron—Dermatitis—Docetaxel—stomach cancer	0.000169	0.00139	CcSEcCtD
Mirabegron—Headache—Docetaxel—stomach cancer	0.000168	0.00138	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000167	0.00137	CcSEcCtD
Mirabegron—Fatigue—Methotrexate—stomach cancer	0.000167	0.00137	CcSEcCtD
Mirabegron—Infection—Doxorubicin—stomach cancer	0.000166	0.00136	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000165	0.00135	CcSEcCtD
Mirabegron—Rash—Capecitabine—stomach cancer	0.000164	0.00134	CcSEcCtD
Mirabegron—Dermatitis—Capecitabine—stomach cancer	0.000163	0.00134	CcSEcCtD
Mirabegron—Tachycardia—Doxorubicin—stomach cancer	0.000163	0.00134	CcSEcCtD
Mirabegron—Headache—Capecitabine—stomach cancer	0.000163	0.00133	CcSEcCtD
Mirabegron—Skin disorder—Doxorubicin—stomach cancer	0.000162	0.00133	CcSEcCtD
Mirabegron—Nausea—Docetaxel—stomach cancer	0.000159	0.00131	CcSEcCtD
Mirabegron—Dyspepsia—Epirubicin—stomach cancer	0.000159	0.00131	CcSEcCtD
Mirabegron—Gastrointestinal pain—Methotrexate—stomach cancer	0.000158	0.0013	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000156	0.00128	CcSEcCtD
Mirabegron—Fatigue—Epirubicin—stomach cancer	0.000156	0.00128	CcSEcCtD
Mirabegron—Constipation—Epirubicin—stomach cancer	0.000155	0.00127	CcSEcCtD
Mirabegron—Nausea—Capecitabine—stomach cancer	0.000154	0.00127	CcSEcCtD
Mirabegron—Urticaria—Methotrexate—stomach cancer	0.000153	0.00126	CcSEcCtD
Mirabegron—Abdominal pain—Methotrexate—stomach cancer	0.000153	0.00125	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000152	0.00125	CcSEcCtD
Mirabegron—Gastrointestinal pain—Epirubicin—stomach cancer	0.000148	0.00121	CcSEcCtD
Mirabegron—Dyspepsia—Doxorubicin—stomach cancer	0.000147	0.00121	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000144	0.00119	CcSEcCtD
Mirabegron—Fatigue—Doxorubicin—stomach cancer	0.000144	0.00118	CcSEcCtD
Mirabegron—Urticaria—Epirubicin—stomach cancer	0.000144	0.00118	CcSEcCtD
Mirabegron—Constipation—Doxorubicin—stomach cancer	0.000143	0.00117	CcSEcCtD
Mirabegron—Abdominal pain—Epirubicin—stomach cancer	0.000143	0.00117	CcSEcCtD
Mirabegron—Asthenia—Methotrexate—stomach cancer	0.000139	0.00114	CcSEcCtD
Mirabegron—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000137	0.00112	CcSEcCtD
Mirabegron—Pruritus—Methotrexate—stomach cancer	0.000137	0.00112	CcSEcCtD
Mirabegron—Urticaria—Doxorubicin—stomach cancer	0.000133	0.00109	CcSEcCtD
Mirabegron—Abdominal pain—Doxorubicin—stomach cancer	0.000132	0.00109	CcSEcCtD
Mirabegron—Diarrhoea—Methotrexate—stomach cancer	0.000132	0.00109	CcSEcCtD
Mirabegron—Asthenia—Epirubicin—stomach cancer	0.00013	0.00106	CcSEcCtD
Mirabegron—Pruritus—Epirubicin—stomach cancer	0.000128	0.00105	CcSEcCtD
Mirabegron—Dizziness—Methotrexate—stomach cancer	0.000128	0.00105	CcSEcCtD
Mirabegron—Diarrhoea—Epirubicin—stomach cancer	0.000124	0.00102	CcSEcCtD
Mirabegron—Rash—Methotrexate—stomach cancer	0.000122	0.001	CcSEcCtD
Mirabegron—Dermatitis—Methotrexate—stomach cancer	0.000122	0.000999	CcSEcCtD
Mirabegron—Headache—Methotrexate—stomach cancer	0.000121	0.000994	CcSEcCtD
Mirabegron—Asthenia—Doxorubicin—stomach cancer	0.00012	0.000985	CcSEcCtD
Mirabegron—Dizziness—Epirubicin—stomach cancer	0.00012	0.000982	CcSEcCtD
Mirabegron—Pruritus—Doxorubicin—stomach cancer	0.000118	0.000972	CcSEcCtD
Mirabegron—Nausea—Methotrexate—stomach cancer	0.000115	0.000942	CcSEcCtD
Mirabegron—Diarrhoea—Doxorubicin—stomach cancer	0.000114	0.00094	CcSEcCtD
Mirabegron—Rash—Epirubicin—stomach cancer	0.000114	0.000936	CcSEcCtD
Mirabegron—Dermatitis—Epirubicin—stomach cancer	0.000114	0.000935	CcSEcCtD
Mirabegron—Headache—Epirubicin—stomach cancer	0.000113	0.00093	CcSEcCtD
Mirabegron—Dizziness—Doxorubicin—stomach cancer	0.000111	0.000908	CcSEcCtD
Mirabegron—Nausea—Epirubicin—stomach cancer	0.000107	0.000882	CcSEcCtD
Mirabegron—Rash—Doxorubicin—stomach cancer	0.000105	0.000866	CcSEcCtD
Mirabegron—Dermatitis—Doxorubicin—stomach cancer	0.000105	0.000865	CcSEcCtD
Mirabegron—Headache—Doxorubicin—stomach cancer	0.000105	0.00086	CcSEcCtD
Mirabegron—Nausea—Doxorubicin—stomach cancer	9.93e-05	0.000816	CcSEcCtD
Mirabegron—ALB—Metabolism—PDHA1—stomach cancer	1.67e-05	0.000396	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ECHS1—stomach cancer	1.67e-05	0.000396	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CA2—stomach cancer	1.67e-05	0.000394	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CD44—stomach cancer	1.65e-05	0.000389	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PLCE1—stomach cancer	1.64e-05	0.000389	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALDH7A1—stomach cancer	1.64e-05	0.000389	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—FYN—stomach cancer	1.63e-05	0.000386	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	1.63e-05	0.000386	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NT5E—stomach cancer	1.62e-05	0.000384	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PGAM1—stomach cancer	1.62e-05	0.000384	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—MMP2—stomach cancer	1.61e-05	0.000381	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.61e-05	0.000381	CbGpPWpGaD
Mirabegron—BCHE—Neuronal System—HRAS—stomach cancer	1.61e-05	0.00038	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.6e-05	0.000378	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PPP2R1A—stomach cancer	1.6e-05	0.000377	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	1.59e-05	0.000377	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—UMPS—stomach cancer	1.58e-05	0.000373	CbGpPWpGaD
Mirabegron—ALB—Metabolism—FADS1—stomach cancer	1.57e-05	0.000372	CbGpPWpGaD
Mirabegron—ALB—Metabolism—TYMP—stomach cancer	1.57e-05	0.000372	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NDUFS1—stomach cancer	1.57e-05	0.000372	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NDUFV1—stomach cancer	1.57e-05	0.000372	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GSTP1—stomach cancer	1.56e-05	0.00037	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PLCE1—stomach cancer	1.55e-05	0.000367	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALDH7A1—stomach cancer	1.55e-05	0.000367	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—CXCL8—stomach cancer	1.54e-05	0.000365	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—HMOX1—stomach cancer	1.54e-05	0.000365	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—FGFR2—stomach cancer	1.53e-05	0.000362	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	1.49e-05	0.000353	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—UMPS—stomach cancer	1.49e-05	0.000351	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SREBF2—stomach cancer	1.47e-05	0.000348	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	1.47e-05	0.000348	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PDHA1—stomach cancer	1.47e-05	0.000347	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ECHS1—stomach cancer	1.47e-05	0.000347	CbGpPWpGaD
Mirabegron—ALB—Metabolism—RORA—stomach cancer	1.46e-05	0.000344	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—TYMS—stomach cancer	1.45e-05	0.000344	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PLAU—stomach cancer	1.45e-05	0.000342	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GSTM1—stomach cancer	1.44e-05	0.00034	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—CAV1—stomach cancer	1.41e-05	0.000334	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	1.41e-05	0.000334	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.41e-05	0.000334	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—APOA1—stomach cancer	1.41e-05	0.000333	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IRS2—stomach cancer	1.4e-05	0.000332	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PGLS—stomach cancer	1.4e-05	0.000332	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—BLVRB—stomach cancer	1.4e-05	0.000332	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PPP2R1A—stomach cancer	1.4e-05	0.000331	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.39e-05	0.000329	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ECHS1—stomach cancer	1.38e-05	0.000327	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PDHA1—stomach cancer	1.38e-05	0.000327	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—TYMP—stomach cancer	1.38e-05	0.000326	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—FADS1—stomach cancer	1.38e-05	0.000326	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GSTP1—stomach cancer	1.37e-05	0.000325	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ALDOB—stomach cancer	1.36e-05	0.000323	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CAV1—stomach cancer	1.36e-05	0.000322	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—APOA1—stomach cancer	1.36e-05	0.000321	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—HMOX1—stomach cancer	1.35e-05	0.00032	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.35e-05	0.00032	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ERCC2—stomach cancer	1.35e-05	0.00032	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PRKCB—stomach cancer	1.34e-05	0.000318	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	1.34e-05	0.000318	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—CXCL8—stomach cancer	1.34e-05	0.000317	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPAP2A—stomach cancer	1.34e-05	0.000316	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.32e-05	0.000313	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.32e-05	0.000313	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—TYMP—stomach cancer	1.3e-05	0.000307	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—FADS1—stomach cancer	1.3e-05	0.000307	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PRKCB—stomach cancer	1.29e-05	0.000306	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SREBF2—stomach cancer	1.29e-05	0.000305	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6ST—stomach cancer	1.29e-05	0.000305	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.29e-05	0.000304	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.28e-05	0.000304	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—TYMS—stomach cancer	1.28e-05	0.000302	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—RORA—stomach cancer	1.28e-05	0.000302	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—MTHFR—stomach cancer	1.27e-05	0.000301	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ALOX5—stomach cancer	1.27e-05	0.0003	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GSTM1—stomach cancer	1.26e-05	0.000298	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.26e-05	0.000298	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.25e-05	0.000296	CbGpPWpGaD
Mirabegron—ALB—Metabolism—DPYD—stomach cancer	1.25e-05	0.000295	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—APC—stomach cancer	1.24e-05	0.000293	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	1.22e-05	0.000289	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SREBF2—stomach cancer	1.22e-05	0.000288	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—RORA—stomach cancer	1.2e-05	0.000284	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALDOB—stomach cancer	1.2e-05	0.000283	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—FBP1—stomach cancer	1.19e-05	0.000282	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.19e-05	0.000282	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CKB—stomach cancer	1.19e-05	0.000282	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CA1—stomach cancer	1.19e-05	0.000282	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—MAPK3—stomach cancer	1.19e-05	0.000281	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ERCC2—stomach cancer	1.19e-05	0.000281	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CAV1—stomach cancer	1.17e-05	0.000277	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—APOA1—stomach cancer	1.17e-05	0.000277	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	1.17e-05	0.000276	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6R—stomach cancer	1.15e-05	0.000272	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.15e-05	0.000272	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.13e-05	0.000267	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—MAPK1—stomach cancer	1.13e-05	0.000267	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—EGFR—stomach cancer	1.13e-05	0.000267	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALDOB—stomach cancer	1.13e-05	0.000266	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PLIN2—stomach cancer	1.12e-05	0.000265	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.12e-05	0.000265	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—SERPINE1—stomach cancer	1.12e-05	0.000265	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—MTHFR—stomach cancer	1.12e-05	0.000264	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALOX5—stomach cancer	1.11e-05	0.000263	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.11e-05	0.000263	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTT1—stomach cancer	1.1e-05	0.000261	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—DPYD—stomach cancer	1.09e-05	0.000259	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP2A6—stomach cancer	1.09e-05	0.000258	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CA2—stomach cancer	1.09e-05	0.000258	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—RHOA—stomach cancer	1.08e-05	0.000255	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—PIK3CA—stomach cancer	1.08e-05	0.000255	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—SERPINE1—stomach cancer	1.08e-05	0.000255	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.07e-05	0.000253	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—NOS3—stomach cancer	1.07e-05	0.000253	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—KRAS—stomach cancer	1.07e-05	0.000252	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NT5E—stomach cancer	1.06e-05	0.000251	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PGAM1—stomach cancer	1.06e-05	0.000251	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AKR1C3—stomach cancer	1.06e-05	0.000251	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALOX5—stomach cancer	1.05e-05	0.000248	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—RHOA—stomach cancer	1.04e-05	0.000246	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ENO1—stomach cancer	1.03e-05	0.000244	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PPARG—stomach cancer	1.03e-05	0.000244	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—DPYD—stomach cancer	1.03e-05	0.000244	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CAV1—stomach cancer	1.03e-05	0.000243	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NOS3—stomach cancer	1.03e-05	0.000243	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—APOA1—stomach cancer	1.03e-05	0.000243	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PLCE1—stomach cancer	1.01e-05	0.00024	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.01e-05	0.00024	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.83e-06	0.000232	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—PIK3CA—stomach cancer	9.8e-06	0.000232	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—UMPS—stomach cancer	9.72e-06	0.00023	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTT1—stomach cancer	9.67e-06	0.000229	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ERBB2—stomach cancer	9.62e-06	0.000228	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP2A6—stomach cancer	9.55e-06	0.000226	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AKR1C3—stomach cancer	9.29e-06	0.00022	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ALB—stomach cancer	9.27e-06	0.000219	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CD44—stomach cancer	9.17e-06	0.000217	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CXCL8—stomach cancer	9.12e-06	0.000216	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTT1—stomach cancer	9.11e-06	0.000215	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—HRAS—stomach cancer	9.06e-06	0.000214	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ENO1—stomach cancer	9.06e-06	0.000214	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PPARG—stomach cancer	9.04e-06	0.000214	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PDHA1—stomach cancer	9.03e-06	0.000214	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ECHS1—stomach cancer	9.03e-06	0.000214	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP2A6—stomach cancer	9e-06	0.000213	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CDKN1B—stomach cancer	8.91e-06	0.000211	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	8.89e-06	0.00021	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—NOS3—stomach cancer	8.86e-06	0.00021	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AKR1C3—stomach cancer	8.76e-06	0.000207	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL6—stomach cancer	8.67e-06	0.000205	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ENO1—stomach cancer	8.53e-06	0.000202	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CCND1—stomach cancer	8.5e-06	0.000201	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—FADS1—stomach cancer	8.49e-06	0.000201	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—TYMP—stomach cancer	8.49e-06	0.000201	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—JUN—stomach cancer	8.48e-06	0.000201	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	8.47e-06	0.0002	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MMP9—stomach cancer	8.25e-06	0.000195	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CDKN1A—stomach cancer	8.22e-06	0.000194	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ALB—stomach cancer	8.13e-06	0.000192	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTGS2—stomach cancer	8.11e-06	0.000192	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CD44—stomach cancer	8.03e-06	0.00019	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAPK8—stomach cancer	8.02e-06	0.00019	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SREBF2—stomach cancer	7.95e-06	0.000188	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—RORA—stomach cancer	7.86e-06	0.000186	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPP2R1A—stomach cancer	7.8e-06	0.000184	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—NOS3—stomach cancer	7.78e-06	0.000184	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—VEGFA—stomach cancer	7.7e-06	0.000182	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTP1—stomach cancer	7.65e-06	0.000181	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CD44—stomach cancer	7.57e-06	0.000179	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HMOX1—stomach cancer	7.54e-06	0.000178	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—VEGFA—stomach cancer	7.41e-06	0.000175	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALDOB—stomach cancer	7.36e-06	0.000174	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—STAT3—stomach cancer	7.34e-06	0.000174	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—MAPK3—stomach cancer	7.28e-06	0.000172	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTGS2—stomach cancer	7.11e-06	0.000168	CbGpPWpGaD
Mirabegron—ALB—Metabolism—TYMS—stomach cancer	7.11e-06	0.000168	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTM1—stomach cancer	7.03e-06	0.000166	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAPK3—stomach cancer	7.01e-06	0.000166	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—MAPK1—stomach cancer	6.93e-06	0.000164	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALOX5—stomach cancer	6.85e-06	0.000162	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPP2R1A—stomach cancer	6.83e-06	0.000162	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MYC—stomach cancer	6.82e-06	0.000161	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—DPYD—stomach cancer	6.73e-06	0.000159	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTP1—stomach cancer	6.7e-06	0.000158	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAPK1—stomach cancer	6.67e-06	0.000158	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—EGFR—stomach cancer	6.67e-06	0.000158	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HMOX1—stomach cancer	6.61e-06	0.000156	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ERCC2—stomach cancer	6.61e-06	0.000156	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—KRAS—stomach cancer	6.54e-06	0.000155	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPP2R1A—stomach cancer	6.44e-06	0.000152	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTP1—stomach cancer	6.31e-06	0.000149	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—KRAS—stomach cancer	6.3e-06	0.000149	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—TYMS—stomach cancer	6.23e-06	0.000147	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HMOX1—stomach cancer	6.23e-06	0.000147	CbGpPWpGaD
Mirabegron—ALB—Metabolism—MTHFR—stomach cancer	6.21e-06	0.000147	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTM1—stomach cancer	6.16e-06	0.000146	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CA—stomach cancer	6.01e-06	0.000142	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTT1—stomach cancer	5.95e-06	0.000141	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP2A6—stomach cancer	5.89e-06	0.000139	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—TYMS—stomach cancer	5.87e-06	0.000139	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—TP53—stomach cancer	5.82e-06	0.000138	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTM1—stomach cancer	5.8e-06	0.000137	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ERCC2—stomach cancer	5.79e-06	0.000137	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CA—stomach cancer	5.79e-06	0.000137	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CAV1—stomach cancer	5.73e-06	0.000135	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AKR1C3—stomach cancer	5.73e-06	0.000135	CbGpPWpGaD
Mirabegron—ALB—Metabolism—APOA1—stomach cancer	5.71e-06	0.000135	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TP53—stomach cancer	5.6e-06	0.000132	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ENO1—stomach cancer	5.58e-06	0.000132	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—HRAS—stomach cancer	5.56e-06	0.000132	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.47e-06	0.000129	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ERCC2—stomach cancer	5.45e-06	0.000129	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—MTHFR—stomach cancer	5.44e-06	0.000129	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—HRAS—stomach cancer	5.35e-06	0.000127	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—MTHFR—stomach cancer	5.13e-06	0.000121	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6—stomach cancer	5.12e-06	0.000121	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPARG—stomach cancer	5.04e-06	0.000119	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CAV1—stomach cancer	5.02e-06	0.000119	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOA1—stomach cancer	5.01e-06	0.000118	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CA—stomach cancer	4.99e-06	0.000118	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CD44—stomach cancer	4.95e-06	0.000117	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CAV1—stomach cancer	4.73e-06	0.000112	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOA1—stomach cancer	4.72e-06	0.000112	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPARG—stomach cancer	4.41e-06	0.000104	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CA—stomach cancer	4.38e-06	0.000104	CbGpPWpGaD
Mirabegron—ALB—Metabolism—NOS3—stomach cancer	4.33e-06	0.000102	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPP2R1A—stomach cancer	4.21e-06	9.95e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPARG—stomach cancer	4.16e-06	9.83e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTP1—stomach cancer	4.13e-06	9.76e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HMOX1—stomach cancer	4.07e-06	9.63e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALB—stomach cancer	3.97e-06	9.38e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTGS2—stomach cancer	3.96e-06	9.37e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—TYMS—stomach cancer	3.84e-06	9.08e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NOS3—stomach cancer	3.79e-06	8.98e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTM1—stomach cancer	3.79e-06	8.97e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALB—stomach cancer	3.74e-06	8.84e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NOS3—stomach cancer	3.58e-06	8.46e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ERCC2—stomach cancer	3.57e-06	8.44e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTGS2—stomach cancer	3.47e-06	8.21e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MTHFR—stomach cancer	3.35e-06	7.93e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTGS2—stomach cancer	3.27e-06	7.74e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CAV1—stomach cancer	3.09e-06	7.31e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOA1—stomach cancer	3.09e-06	7.3e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPARG—stomach cancer	2.72e-06	6.43e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALB—stomach cancer	2.44e-06	5.78e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CA—stomach cancer	2.44e-06	5.76e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NOS3—stomach cancer	2.34e-06	5.53e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTGS2—stomach cancer	2.14e-06	5.06e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CA—stomach cancer	2.14e-06	5.05e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.01e-06	4.76e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.32e-06	3.11e-05	CbGpPWpGaD
